Utilising organs from hepatitis C virus PCR-positive donors in Western Australia

Peter Boan, Jagadish Jamboti, Michael Musk, Melanie Lavender, Jeremy P. Wrobel, Felicity Lee, Amit Shah, Lynette A. Pereira, J. Owen Robinson, Ashley Irish

Research output: Contribution to journalArticlepeer-review

Abstract

We transplanted six solid organs from three hepatitis C virus (HCV) polymerase chain reaction (PCR)-positive donors during 2018–2023. Recipients were treated with glecaprevir/pibrentasvir or sofosbuvir/velpatasvir for 4–12 weeks, with all six achieving sustained virological response without significant adverse events. As occurs in other jurisdictions, solid organ transplants from HCR PCR-positive donors can be safely utilised in Australia.

Original languageEnglish
Pages (from-to)678-681
Number of pages4
JournalInternal Medicine Journal
Volume54
Issue number4
DOIs
Publication statusPublished - Apr 2024

Fingerprint

Dive into the research topics of 'Utilising organs from hepatitis C virus PCR-positive donors in Western Australia'. Together they form a unique fingerprint.

Cite this